Disease/Infection News

RSS

Protection against SARS-CoV-2 Omicron afforded by Pfizer-BioNTech and Moderna boosters compared to two-dose primary series

The current paper compares the effectiveness of two vs. three doses of these vaccines against Omicron compared to Delta.

25 Jan 2022

Scientists develop a model to rapidly identify vaccine breakthrough SARS-CoV-2 variants

In a new study, scientists have recently developed a computational model to predict the antigenicity and immune escape ability of emerging variants of SARS-CoV-2.

25 Jan 2022

Sensitivity and specificity of a “spit and mail” SARS-CoV-2 serology test

A recent study evaluated the sensitivity and specificity of a “spit and mail” serology test.

25 Jan 2022

Study suggests COVID-19 patient fatalities are decreasing unequally in vaccinated and unvaccinated countries

Researchers from the University of London have been exploring the case-fatality rate of COVID-19 in the top-vaccinated countries compared to the rest of the world.

25 Jan 2022

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

In a new study, exhaled aerosols were compared between infected SARS-CoV-2 patients and healthy controls for the first time. A preprint version of this study, which is yet to undergo peer review, is available on the medRxiv* server.

24 Jan 2022

In Portugal risk of hospitalization from Omicron is 75% lower than Delta

Researchers from Portugal reported a 75% risk reduction in hospitalizations for individuals infected with Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared to the Delta variant and a shorter length of stay and lower mortality if hospitalization does occur. Their paper is currently available on the medRxiv* preprint server while undergoing peer review.

24 Jan 2022

LA County study finds COVID-19 'herd immunity' unlikely

In a research letter published in the Journal of the American Medical Association (JAMA), researchers carried out a seroprevalence and vaccination coverage study in Los Angeles County (LAC).

24 Jan 2022

Neurological complications of the SARS-CoV-2 vaccine

In a study published in the latest issue of the journal Neurological Sciences, a team of researchers described a three-patient case series presenting with neurological manifestations after the coronavirus disease 2019 (COVID-19) vaccination, followed by a literature review, to propose hypotheses on how neurological symptoms might develop after vaccination.

24 Jan 2022

Majority of COVID-19 survivors experience health problems one-year post ICU admission

75% of the COVID-19 survivors who were treated in the Intensive Care Unit (ICU) experience physical, mental and/or cognitive problems one-year post ICU.

24 Jan 2022

Danish study shows lower risk of hospitalization in Omicron cases compared to Delta

In a recent study posted to the Preprints with The Lancet* server, a large team of researchers estimated the comparative risk of hospitalization after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and Delta variants of concern (VOCs) in Denmark.

24 Jan 2022

The long-term neurologic consequences of COVID-19

A team of researchers recently provided insights into central nervous system consequences of the coronavirus disease 2019 (COVID-19) in a perspective paper published in the Science journal.

24 Jan 2022

Eligible adults urged to take part in world-first COVID-19 study of antivirals

Adults over the age of 50 or with an underlying health condition who test positive for COVID-19 are being urged to sign up for a world-first COVID-19 study which is providing life-saving antivirals to thousands of people.

24 Jan 2022

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

A new approach that targets the cellular machinery that viruses need to reproduce – rather than the virus itself – appears to stem replication of a common childhood pathogen known as respiratory syncytial virus (RSV), UT Southwestern researchers report in a new study.

24 Jan 2022

New, low-cost COVID-19 test could make high-performance testing more accessible

Researchers at the University of Washington have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests that are processed in medical labs and hospitals.

24 Jan 2022

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

In a study published in the latest issue of the Scientific Reports, a team of researchers constructed virus-like particles (VLPs) composed of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M), envelope (E), and nucleocapsid (N) proteins in tobacco plant using Agrobacterium-mediated delivery.

24 Jan 2022

Lower risk of vaccine-breakthrough infections for mRNA-1273 recipients

Recently, a team of researchers examined breakthrough infections, hospitalizations, and mortality rates in double-dose messenger RNA (mRNA) vaccine recipients in a research letter published in the Journal of American Medical Association (JAMA).

24 Jan 2022

Experts issue new CPR guidance addressing highly contagious variants of SARS-CoV-2

In response to the COVID-19 pandemic, the American Heart Association and collaborating organizations, including the American Academy of Pediatrics, the American Association for Respiratory Care, the Society of Critical Care Anesthesiologists and the American Society of Anesthesiologists, continue to provide interim guidance to address the latest scientific research related to the SARS-CoV-2 virus, particularly the Delta and Omicron variants.

24 Jan 2022

Why Medicare doesn’t pay for rapid at-home covid tests

What group is especially vulnerable to the ravages of covid-19 even if fully vaccinated and boosted? Seniors. And who will have an especially tough time getting free at-home covid tests under the Biden administration's plan? Yes, seniors.

24 Jan 2022

Researchers examine benefits of lateral flow testing with regards to the new Paxlovid drug for treatment of COVID-19

In a new study, researchers from Harvard University explored the benefits of different COVID-19 testing schemes with regards to the new Paxlovid drug.

24 Jan 2022

Study explains why Omicron infections are less likely to cause severe disease

A new study by researchers from the University of Kent and the Goethe University Frankfurt shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defense mechanism against viruses, the so-called “interferon response”.

24 Jan 2022

Disease/Infection News

Protection against SARS-CoV-2 Omicron afforded by Pfizer-BioNTech and Moderna boosters compared to two-dose primary series

Scientists develop a model to rapidly identify vaccine breakthrough SARS-CoV-2 variants

Sensitivity and specificity of a “spit and mail” SARS-CoV-2 serology test

Study suggests COVID-19 patient fatalities are decreasing unequally in vaccinated and unvaccinated countries

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

In Portugal risk of hospitalization from Omicron is 75% lower than Delta

LA County study finds COVID-19 'herd immunity' unlikely

Neurological complications of the SARS-CoV-2 vaccine

Majority of COVID-19 survivors experience health problems one-year post ICU admission

Danish study shows lower risk of hospitalization in Omicron cases compared to Delta

The long-term neurologic consequences of COVID-19

Eligible adults urged to take part in world-first COVID-19 study of antivirals

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

New, low-cost COVID-19 test could make high-performance testing more accessible

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

Lower risk of vaccine-breakthrough infections for mRNA-1273 recipients

Experts issue new CPR guidance addressing highly contagious variants of SARS-CoV-2

Why Medicare doesn’t pay for rapid at-home covid tests

Researchers examine benefits of lateral flow testing with regards to the new Paxlovid drug for treatment of COVID-19

Study explains why Omicron infections are less likely to cause severe disease

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News